Related Experiment Video
Updated: Aug 2, 2026

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature
Published on: April 1, 2014
Binding of bacterial peptidoglycan to CD14
R Dziarski1, R I Tapping, P S Tobias
1Northwest Center for Medical Education, Indiana University School of Medicine, Gary, Indiana 46408, USA. rdziar@iunhaw1.iun.indiana.edu
Soluble peptidoglycan (sPGN) activates macrophages by binding to CD14, a receptor typically for lipopolysaccharide (LPS). This study confirms sPGN-CD14 binding, revealing partially overlapping binding sites with LPS.
Area of Science:
- Immunology
- Microbiology
- Molecular Biology
Background:
- Soluble peptidoglycan (sPGN) from Gram-positive bacteria is a known macrophage activator.
- CD14 is a well-established receptor for lipopolysaccharide (LPS), a component of Gram-negative bacteria.
- The interaction between sPGN and CD14 has been hypothesized but required detailed investigation.
Purpose of the Study:
- To experimentally validate the hypothesis that soluble peptidoglycan (sPGN) binds to the CD14 receptor.
- To characterize the binding kinetics and specificity of sPGN interaction with CD14.
- To compare the binding of sPGN to CD14 with that of lipopolysaccharide (LPS).
Main Methods:
- Utilized three distinct binding assays: sPGN-immobilized assays with soluble 32P-labeled CD14 (sCD14), enzyme-linked immunosorbent assay (ELISA), and photoaffinity cross-linking.
- Investigated competitive inhibition using various molecules including unlabeled sCD14, CD14 fragments, LPS, lipid A, and lipoteichoic acid.
- Assessed the influence of LPS-binding protein (LBP) on sCD14 binding to sPGN and LPS.
- Employed anti-CD14 monoclonal antibodies (mAbs) to probe for distinct binding sites.
Main Results:
- Confirmed specific binding of sPGN to CD14 across all tested assays.
- Demonstrated that sPGN binds to CD14 with higher affinity (KD = 25 nM) than LPS (KD = 41 nM), although binding is slower.
- Showed that LPS-binding protein (LBP) modulates sCD14 binding differently for sPGN and LPS, enhancing affinity for LPS.
- Identified partially overlapping, yet distinct, conformational binding sites on CD14 for sPGN and LPS, evidenced by differential mAb inhibition.
Conclusions:
- Soluble peptidoglycan (sPGN) directly binds to CD14, extending the known ligand repertoire of this receptor beyond LPS.
- The binding interaction between sPGN and CD14 involves specific molecular recognition and exhibits distinct characteristics compared to LPS binding.
- These findings elucidate a novel mechanism for sPGN-mediated immune activation via CD14 and highlight the receptor's versatility.
More Related Videos
Related Concept Videos
Cytoskeletal Proteins in Bacteria
Bacterial Cell Wall
Peptidoglycan Synthesis
Formation of Lipopolysaccharides
Bacterial Toxins
Inhibitors of Gram-positive Cell Wall Synthesis

